Health Care Equipment

PEIJIA-B

PEIJIA-B released FY2025 9 Months earnings on March 25 (BJT), actual revenue HKD 579.11 M, actual EPS HKD -0.2233

PEIJIA-B released FY2025 Q3 earnings on March 25, 2026 (BJT) with actual revenue HKD 0 and actual EPS HKD 0

PEIJIA-B released FY2025 earnings on March 25 Pre-Market (BJT), actual revenue HKD 779.14 M (forecast HKD 839.85 M), actual EPS HKD -0.3339 (forecast HKD -0.1957)

PEIJIA-B released FY2025 Q4 earnings on March 25 Pre-Market (BJT), actual revenue HKD 199.88 M, actual EPS HKD -0.1116

PepGen's DCwire Microguidewire Receives FDA 510(k) Approval

PEIJIA-B to Release FY2025 Earnings on March 25 Pre-Market (BJT), Forecast Revenue HKD 829.9 M, EPS HKD -0.197

Pepgen Medical-B Submits GeminiOne® EU MDR CE Mark Registration Application

PepGen Medical Reports Unaudited Revenue Growth of 13.7% to 17.0% to RMB 700m to 720m in 2025

Pebao Medical-B Receives Registration Approval for TaurusTrio™ TAV System

PepGen's TaurusNXT® TAVR System's Registration Application Accepted by NMPA

PepGen CEO Buys Company Shares

Dr. Zhang Yi, Chairman of Peige Medical, Increases Shareholding

Peige Medtech-B Received NMPA Acceptance Confirmation Letter for GeminiOne® System Registration Application

Peijia Medical Successfully Completes First ReachTactile™ Robot-Assisted TAVR Procedure

Suzhou Hengtai Signs Strategic Cooperation Agreement with MicroPort Medical

Peijia Medical Reports Mid-Year Earnings: Total Revenue Up 17.3%, Cost Ratios Decline Across Business Segments

PEIJIA-B released FY2025 Q1 earnings on August 22 (BJT), actual revenue HKD 189.23 M, actual EPS HKD -0.0561

PepGen-B Announces Q2 2025 Results with Revenue and Gross Margin Growth

PEIJIA-B released FY2025 Q2 earnings on August 22 Pre-Market (BJT), actual revenue HKD 193.39 M, actual EPS HKD -0.0574

PEIJIA-B released FY2025 Semi-Annual Earnings on August 22 Pre-Market (BJT), actual revenue HKD 382.62 M, actual EPS HKD -0.1136

FAMEGLOW

HAICHANG HLDG

TJCD

NEW GONOW RV

HUISHENG INTL

CH DEMETER FIN

ZHONGSHENJIANYE

51WORLD

SAU SAN TONG

09996

<p>Peijia Medical Ltd. announced that its chairman and CEO, Dr. Yi Zhang, plans to purchase shares worth up to HK$15 million starting March 26, 2026, to increase his stake in the company. This move reflects his confidence in the company's value and growth potential. The company assures that it will maintain sufficient public float under Hong Kong listing rules. The latest analyst rating for Peijia Medical (HK:9996) is a Hold with a price target of HK$6.50.</p>

Tip Ranks

Peijia Medical Chair and CEO to Boost Stake with HK$15 Million Share Purchase

<p>PEIJIA-B announced its 2025 annual performance, with revenue recorded at RMB 713 million, an increase of 15.8% year-on-year. The loss narrowed from RMB 227 million in the previous year to RMB 203 million, with a loss per share of 31 cents. No final dividend is declared</p>

AASTOCKS

"Performance" Peijia Medical's annual loss narrowed to 203 million yuan

PEIJIA-B(09996.HK)

Peijia Medical Chair and CEO to Boost Stake with HK$15 Million Share Purchase

"Performance" Peijia Medical's annual loss narrowed to 203 million yuan